Combinations of serotonin reuptake inhibitors and imidazoline-I2-agonists

Details for Australian Patent Application No. 2004313648 (hide)

Owner Merck Patent GmbH

Inventors Seyfried, Christoph; Bartoszyk, Gerd; Van Amsterdam, Christoph; Boettcher, Henning

Agent Davies Collison Cave

Pub. Number AU-B-2004313648

PCT Pub. Number WO2005/067969

Priority 10 2004 002 638.6 19.01.04 DE

Filing date 15 December 2004

Wipo publication date 28 July 2005

Acceptance publication date 30 September 2010

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/4178 (2006.01)

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/067969 Priority application(s): WO2005/067969

30 September 2010 Application Accepted

  Published as AU-B-2004313648

27 January 2011 Standard Patent Sealed

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004313651-Vapour-liquid distribution tray

2004313616-Casting machine